Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2012

View Archived Issues

AstraZeneca highlights key events of fourth quarter and FY2011

Japanese study compares drugs to retard symptom progression after stroke

Carbon nanomaterials display antioxidant characteristics

Pfizer prepares new voltage-gated K(V)7.2 and K(V)7.3 potassium channel openers

New melanin-concentrating hormone MCH1 receptor modulators disclosed

Mitsubishi Tanabe Pharma recaps recent highlights

Recordati presents new metabotropic glutamate mGlu5 receptor antagonists

Novel vaccine against C. perfringens patented in India

New compounds extracted from Cymbidium disclosed by Kawano Mericlone

Cormus designs novel lipid-conjugated antibodies

Significant benefit seen with adalimumab in ulcerative colitis

Detailed results presented of phase III regorafenib study

Forest Laboratories and Gedeon Richter report phase III cariprazine data

Milestones achieved in Pepscan Therapeutics/Janssen R&D Ireland collaboration

RedHill receives approval from Health Canada to begin RHB-102 trial

GSK launches over-the-counter cold sore product in Europe

ImmunoCellular Therapeutics provides pipeline update

New stem cell therapy improves stroke outcome in preclinical models

Cytomedix completes acquisition

Wellcome Trust launches new scheme to fund early-stage research in orphan and neglected diseases

Prometheus Laboratories enters collaboration with leading pharmaceutical company

Moberg Derma analyzes phase II data on nail fungus therapy

Ironwood Pharmaceuticals gives update on linaclotide NDA

MRF to assess ENDECE Neural's myelin regenerative compounds for MS

Siemens enters partnerships with ViiV Healthcare and Tocagen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...